Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP).

被引：0
|
作者：
Orlando, M
Wozniak, A
Janne, P
Belani, CP
Keohan, ML
Ross, H
Polikoff, J
Mintzer, D
Bloss, L
Obasaju, C
机构：
[1] Lilly Res Labs, Indianapolis, IN USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Columbia Presbyterian Med Ctr, New York, NY 10032 USA
[5] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[6] Kaiser Hosp San Diego, San Diego, CA USA
[7] Penn Hosp, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7195
引用
收藏
页码：664S / 664S
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: A phase I/II study in Japanese patients
    Nakagawa, Kazuhiko
    Yamazaki, Koichi
    Kunitoh, Hideo
    Hida, Toyoaki
    Gemba, Kenichi
    Shinkai, Tetsu
    Ichinose, Yukito
    Adachi, Susumu
    Nambu, Yoshihiro
    Saijo, Nagahiro
    Fukuoka, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (05) : 339 - 346
  • [42] Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated after first line chemotherapy (CT)
    Cedres, S.
    Amair, F.
    Martinez-Marti, A.
    Navarro, A.
    Pardo, N.
    Remon-Masip, J.
    Miquel, J. M.
    Villacampa, G.
    Dienstmann, R.
    Felip Font, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S131 - S132
  • [43] QUALITY OF LIFE (QOL) IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) TREATED WITH CHEMOTHERAPY
    Van Meerbeeck, J.
    Gaafar, R.
    Manegold, C.
    Burgers, S.
    Coens, C.
    Legrand, C.
    Vincent, M.
    Giaccone, G.
    Bottomley, A.
    QUALITY OF LIFE RESEARCH, 2005, 14 (09) : 2141 - 2141
  • [44] Successful Salvage Chemotherapy with Gemcitabine and Vinorelbine in a Malignant Pleural Mesothelioma Patient Previously Treated with Pemetrexed
    Agatsuma, Toshihiko
    Koizumi, Tomonobu
    Yasuo, Masanori
    Urushihata, Kazuhisa
    Tsushima, Kenji
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Fukushima, Mana
    Honda, Takayuki
    Kubo, Keishi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (12) : 1180 - 1183
  • [45] Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of malignant pleural mesothelioma (MPM)
    Rea, F.
    Favaretto, A. G.
    Marulli, G.
    Spaggiari, L.
    De Pas, T. M.
    Ceribelli, A.
    Paccagnella, A.
    Crivellari, G.
    Russo, F.
    Ceccarelli, M.
    Facciolo, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
    Nakano, Takashi
    Kuribayashi, Kozo
    Kondo, Masashi
    Morise, Masahiro
    Tada, Yuji
    Hirano, Katsuya
    Hayashi, Morihiko
    Tanaka, Misa
    Hirabayashi, Masataka
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (03) : 264 - 272
  • [47] Phase 2 study of tremelimumab plus durvalumab for previously-treated malignant pleural mesothelioma (MPM).
    Venkatraman, Deepti
    Anderson, Adrienne
    Digumarthy, Subba
    Lizotte, Patrick H.
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study
    De Vincenzo, F.
    Zucali, P.
    Ceresoli, G.
    Gianoncelli, L.
    Lorenzi, E.
    Simonelli, M.
    Ripa, C.
    Giordano, L.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Long-term survival update from the randomized phase III study of pemetrexed plus cisplatin vs cisplatin in patients with malignant pleural mesothelioma (MPM)
    Vogelzang, N
    Symanowski, J
    Rusthoven, J
    Manegold, C
    Boyer, M
    Nguyen, B
    Paoletti, R
    LUNG CANCER, 2005, 49 : S231 - S231
  • [50] Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients
    Shukuya, Takehito
    Takahashi, Toshiaki
    Imai, Hisao
    Tokito, Takaaki
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Yamamoto, Nobuyuki
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 101 - 106
12345